Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis. 2012

Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Firat University, Faculty of Medicine, Elazig, Turkey. ulusoyh@mynet.com

The aim of this study was to assess serum levels and clinical significance of soluble CD26 (sCD26) and soluble CD30 (sCD30) in patients with rheumatoid arthritis (RA). Forty-eight patients with RA and 30 healthy controls were enrolled. Serum sCD26 and sCD30 levels were measured using ELISA. Serum sCD26 levels were significantly lower (P = 0.011), whereas sCD30 levels were higher (P = 0.008) in patients with RA than controls. Serum levels of sCD30 correlated significantly with clinical and laboratory parameters of disease activity like erythrocyte sedimentation rate, C-reactive protein, disease activity scores-28 and health assessment questionnaire score; however, sCD26 levels did not correlate any of these activity parameters. These results suggest that serum sCD30 levels increased and correlated significantly with disease activity, indicating a novel follow-up parameter in RA. Serum levels of sCD26 may be lessen but not related to disease activity in RA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D017730 Ki-1 Antigen A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. Antigens, CD30,Antigens, Ki-1,Ber-H2 Antigens,CD30 Antigens,Ki-1 Antigens,Tumor Necrosis Factor Receptor Superfamily, Member 8,Ber-H2 Antigen,CD30 Antigen,TNFRSF8 Receptor,Antigen, Ber-H2,Antigen, CD30,Antigen, Ki-1,Antigens, Ber-H2,Antigens, Ki 1,Ber H2 Antigen,Ber H2 Antigens,Ki 1 Antigen,Ki 1 Antigens,Receptor, TNFRSF8
D018819 Dipeptidyl Peptidase 4 A serine protease that catalyses the release of an N-terminal dipeptide. Several biologically-active peptides have been identified as dipeptidyl peptidase 4 substrates including INCRETINS; NEUROPEPTIDES; and CHEMOKINES. The protein is also found bound to ADENOSINE DEAMINASE on the T-CELL surface and is believed to play a role in T-cell activation. Antigens, CD26,CD26 Antigens,Dipeptidyl-Peptidase IV,Adenosine Deaminase Complexing Protein 2,CD26 Antigen,Antigen, CD26,Dipeptidyl Peptidase IV

Related Publications

Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
January 2020, BioMed research international,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
June 2002, Nephron,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
July 2007, The Journal of infection,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
January 2013, Journal of investigational allergology & clinical immunology,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
October 2001, Rheumatology international,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
October 2008, Journal of dermatological science,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
January 2006, Journal of neurology,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
April 2008, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
January 2015, PloS one,
Hasan Ulusoy, and Ayhan Kamanli, and Necip Ilhan, and Omer Kuru, and Sule Arslan, and Gokhan Alkan, and Salih Ozgocmen
January 1998, Clinical and experimental rheumatology,
Copied contents to your clipboard!